TRS01
Non‑infectious anterior uveitis (including uveitic glaucoma)
Phase 2Active
Key Facts
Indication
Non‑infectious anterior uveitis (including uveitic glaucoma)
Phase
Phase 2
Status
Active
Company
About Tarsier Pharma
Innovative immunomodulator platform for ocular inflammatory diseases, advancing multiple candidates toward late‑stage trials.
View full company profile